A citation-based method for searching scientific literature

Shaden A M Khalifa, Nermeen Yosri, Mohamed F El-Mallah, Reem Ghonaim, Zhiming Guo, Syed Ghulam Musharraf, Ming Du, Alfi Khatib, Jianbo Xiao, Aamer Saeed, Haged H R El-Seedi, Chao Zhao, Thomas Efferth, Hesham R El-Seedi. Phytomedicine 2021
Times Cited: 17







List of co-cited articles
123 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.
Zhenming Jin, Xiaoyu Du, Yechun Xu, Yongqiang Deng, Meiqin Liu, Yao Zhao, Bing Zhang, Xiaofeng Li, Leike Zhang, Chao Peng,[...]. Nature 2020
41

Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir.
Wanchao Yin, Chunyou Mao, Xiaodong Luan, Dan-Dan Shen, Qingya Shen, Haixia Su, Xiaoxi Wang, Fulai Zhou, Wenfeng Zhao, Minqi Gao,[...]. Science 2020
460
35

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Manli Wang, Ruiyuan Cao, Leike Zhang, Xinglou Yang, Jia Liu, Mingyue Xu, Zhengli Shi, Zhihong Hu, Wu Zhong, Gengfu Xiao. Cell Res 2020
35

Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data.
Muhammad T Islam, Chandan Sarkar, Dina M El-Kersh, Sarmin Jamaddar, Shaikh J Uddin, Jamil A Shilpi, Mohammad S Mubarak. Phytother Res 2020
74
29

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.
Linlin Zhang, Daizong Lin, Xinyuanyuan Sun, Ute Curth, Christian Drosten, Lucie Sauerhering, Stephan Becker, Katharina Rox, Rolf Hilgenfeld. Science 2020
29

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.
Canrong Wu, Yang Liu, Yueying Yang, Peng Zhang, Wu Zhong, Yali Wang, Qiqi Wang, Yang Xu, Mingxue Li, Xingzhou Li,[...]. Acta Pharm Sin B 2020
830
29

Structure of the RNA-dependent RNA polymerase from COVID-19 virus.
Yan Gao, Liming Yan, Yucen Huang, Fengjiang Liu, Yao Zhao, Lin Cao, Tao Wang, Qianqian Sun, Zhenhua Ming, Lianqi Zhang,[...]. Science 2020
578
29

Drug targets for corona virus: A systematic review.
Manisha Prajapat, Phulen Sarma, Nishant Shekhar, Pramod Avti, Shweta Sinha, Hardeep Kaur, Subodh Kumar, Anusuya Bhattacharyya, Harish Kumar, Seema Bansal,[...]. Indian J Pharmacol 2020
192
23


In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.
Mahmoud A A Ibrahim, Alaa H M Abdelrahman, Taha A Hussien, Esraa A A Badr, Tarik A Mohamed, Hesham R El-Seedi, Paul W Pare, Thomas Efferth, Mohamed-Elamir F Hegazy. Comput Biol Med 2020
42
23

A pneumonia outbreak associated with a new coronavirus of probable bat origin.
Peng Zhou, Xing-Lou Yang, Xian-Guang Wang, Ben Hu, Lei Zhang, Wei Zhang, Hao-Rui Si, Yan Zhu, Bei Li, Chao-Lin Huang,[...]. Nature 2020
23

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.
Jun Lan, Jiwan Ge, Jinfang Yu, Sisi Shan, Huan Zhou, Shilong Fan, Qi Zhang, Xuanling Shi, Qisheng Wang, Linqi Zhang,[...]. Nature 2020
23

A Novel Coronavirus from Patients with Pneumonia in China, 2019.
Na Zhu, Dingyu Zhang, Wenling Wang, Xingwang Li, Bo Yang, Jingdong Song, Xiang Zhao, Baoying Huang, Weifeng Shi, Roujian Lu,[...]. N Engl J Med 2020
23

Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study.
Davide Gentile, Vincenzo Patamia, Angela Scala, Maria Teresa Sciortino, Anna Piperno, Antonio Rescifina. Mar Drugs 2020
104
17

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
17

Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava.
Ji-Young Park, Jang Hoon Kim, Jung Min Kwon, Hyung-Jun Kwon, Hyung Jae Jeong, Young Min Kim, Doman Kim, Woo Song Lee, Young Bae Ryu. Bioorg Med Chem 2013
67
17

Coronaviruses: an overview of their replication and pathogenesis.
Anthony R Fehr, Stanley Perlman. Methods Mol Biol 2015
17

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.
Alexandra C Walls, Young-Jun Park, M Alejandra Tortorici, Abigail Wall, Andrew T McGuire, David Veesler. Cell 2020
17

Natural-like products as potential SARS-CoV-2 Mpro inhibitors: in-silico drug discovery.
Mahmoud A A Ibrahim, Khlood A A Abdeljawaad, Alaa H M Abdelrahman, Mohamed-Elamir F Hegazy. J Biomol Struct Dyn 2021
30
17

Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients.
Hai-Xia Su, Sheng Yao, Wen-Feng Zhao, Min-Jun Li, Jia Liu, Wei-Juan Shang, Hang Xie, Chang-Qiang Ke, Hang-Chen Hu, Mei-Na Gao,[...]. Acta Pharmacol Sin 2020
108
17


Ethnomedicines of Indian origin for combating COVID-19 infection by hampering the viral replication: using structure-based drug discovery approach.
Selvaraj Alagu Lakshmi, Raja Mohamed Beema Shafreen, Arumugam Priya, Karutha Pandian Shunmugiah. J Biomol Struct Dyn 2021
20
17

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.
Wenhao Dai, Bing Zhang, Xia-Ming Jiang, Haixia Su, Jian Li, Yao Zhao, Xiong Xie, Zhenming Jin, Jingjing Peng, Fengjiang Liu,[...]. Science 2020
488
17

PLIP: fully automated protein-ligand interaction profiler.
Sebastian Salentin, Sven Schreiber, V Joachim Haupt, Melissa F Adasme, Michael Schroeder. Nucleic Acids Res 2015
590
17

Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study.
Qingxian Cai, Minghui Yang, Dongjing Liu, Jun Chen, Dan Shu, Junxia Xia, Xuejiao Liao, Yuanbo Gu, Qiue Cai, Yang Yang,[...]. Engineering (Beijing) 2020
539
17


The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.
Jin-Yan Li, Zhi You, Qiong Wang, Zhi-Jian Zhou, Ye Qiu, Rui Luo, Xing-Yi Ge. Microbes Infect 2020
144
17

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.
Leon Caly, Julian D Druce, Mike G Catton, David A Jans, Kylie M Wagstaff. Antiviral Res 2020
765
17

Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.
Ka-Tim Choy, Alvina Yin-Lam Wong, Prathanporn Kaewpreedee, Sin Fun Sia, Dongdong Chen, Kenrie Pui Yan Hui, Daniel Ka Wing Chu, Michael Chi Wai Chan, Peter Pak-Hang Cheung, Xuhui Huang,[...]. Antiviral Res 2020
402
17

Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge.
Francesca Picarazzi, Ilaria Vicenti, Francesco Saladini, Maurizio Zazzi, Mattia Mori. Molecules 2020
20
17

α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment.
Linlin Zhang, Daizong Lin, Yuri Kusov, Yong Nian, Qingjun Ma, Jiang Wang, Albrecht von Brunn, Pieter Leyssen, Kristina Lanko, Johan Neyts,[...]. J Med Chem 2020
206
17


Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
17

Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19.
Andresa Aparecida Berretta, Marcelo Augusto Duarte Silveira, José Manuel Cóndor Capcha, David De Jong. Biomed Pharmacother 2020
47
17

Inhibition of human coronavirus NL63 infection at early stages of the replication cycle.
Krzysztof Pyrc, Berend Jan Bosch, Ben Berkhout, Maarten F Jebbink, Ronald Dijkman, Peter Rottier, Lia van der Hoek. Antimicrob Agents Chemother 2006
81
11

Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2).
Noor Rahman, Zarrin Basharat, Muhammad Yousuf, Giuseppe Castaldo, Luca Rastrelli, Haroon Khan. Molecules 2020
67
11

Inhibition of SARS-CoV 3CL protease by flavonoids.
Seri Jo, Suwon Kim, Dong Hae Shin, Mi-Sun Kim. J Enzyme Inhib Med Chem 2020
239
11

Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
Guangdi Li, Erik De Clercq. Nat Rev Drug Discov 2020
772
11

Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA-dependent RNA polymerase (RdRp) inhibition: an in-silico analysis.
Satyam Singh, Md Fulbabu Sk, Avinash Sonawane, Parimal Kar, Sushabhan Sadhukhan. J Biomol Struct Dyn 2021
35
11

Marine compounds and their antiviral activities.
Jarred Yasuhara-Bell, Yuanan Lu. Antiviral Res 2010
91
11

Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2-a molecular dynamic study.
Muhammad Tahir Khan, Arif Ali, Qiankun Wang, Muhammad Irfan, Abbas Khan, Muhammad Tariq Zeb, Yu-Juan Zhang, Sathishkumar Chinnasamy, Dong-Qing Wei. J Biomol Struct Dyn 2021
61
11

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.
Graham Simmons, Dhaval N Gosalia, Andrew J Rennekamp, Jacqueline D Reeves, Scott L Diamond, Paul Bates. Proc Natl Acad Sci U S A 2005
603
11

Coronavirus puts drug repurposing on the fast track.
Charlotte Harrison. Nat Biotechnol 2020
246
11

Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?
Mirko Baglivo, Manuela Baronio, Giuseppe Natalini, Tommaso Beccari, Pietro Chiurazzi, Ezio Fulcheri, Paolo Pietro Petralia, Sandro Michelini, Giovanni Fiorentini, Giacinto Abele Miggiano,[...]. Acta Biomed 2020
54
11

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.
Wenhui Li, Michael J Moore, Natalya Vasilieva, Jianhua Sui, Swee Kee Wong, Michael A Berne, Mohan Somasundaran, John L Sullivan, Katherine Luzuriaga, Thomas C Greenough,[...]. Nature 2003
11

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry.
Heike Hofmann, Krzysztof Pyrc, Lia van der Hoek, Martina Geier, Ben Berkhout, Stefan Pöhlmann. Proc Natl Acad Sci U S A 2005
419
11

Curcumin as a potential treatment for COVID-19.
Francisco Airton Castro Rocha, Marcos Renato de Assis. Phytother Res 2020
9
22

Artemisia annua: Trials are needed for COVID-19.
Faiz Ul Haq, Muhammad Roman, Kashif Ahmad, Saeed Ur Rahman, Syed Murtaza Ali Shah, Naveed Suleman, Sami Ullah, Iftekhar Ahmad, Wajahat Ullah. Phytother Res 2020
17
11

Natural products as home-based prophylactic and symptom management agents in the setting of COVID-19.
Sai Manohar Thota, Venkatesh Balan, Venketesh Sivaramakrishnan. Phytother Res 2020
15
13

Should we try the antiinflammatory natural product, celastrol, for COVID-19?
Solomon Habtemariam, Seyed Fazel Nabavi, Ioana Berindan-Neagoe, Cosmin Andrei Cismaru, Morteza Izadi, Antoni Sureda, Seyed Mohammad Nabavi. Phytother Res 2020
9
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.